vVARDIS Achieves Unicorn Status with Apollo Investment
vVARDIS Holding AG, a high-growth dental medtech company, has announced a strategic minority investment from Apollo-managed funds, marking its achievement of unicorn status. This investment will support the company’s global growth and expansion of its Curodont™ product line.
ZUG, Switzerland–(BUSINESS WIRE)–vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, health